Skip to content
Bispecific Antibodies: A New-Age Cancer Immunotherapy to Battle Solid Tumors

Bispecific Antibodies: A New-Age Cancer Immunotherapy to Battle Solid Tumors

Innovations in therapeutic approaches have drastically improved the outcomes of non-small cell lung cancer (NSCLC) in recent years. Among those, molecular targeted therapies, commonly involving small molecule compounds or monoclonal ...
Read More
An Outstanding Year for Proteintech Group at the 2025 CiteAb Awards!

An Outstanding Year for Proteintech Group at the 2025 CiteAb Awards!

We are delighted to share that the Proteintech ...
Proud to Have Taken Part in the MBKE & MAGE Molecular Life Sciences Conference with Great Success!

Proud to Have Taken Part in the MBKE & MAGE Molecular Life Sciences Conference with Great Success!

We were pleased to participate in the molecular ...
Bio-Kasztel starter set

Bio-Kasztel starter set

A creative snapshot of us, from the office, ...

Let’s connect!

Inquire now for tailored lab equipment and services.

Request a quote